ASP Isotopes (NASDAQ:ASPI) Shares Gap Up – Still a Buy?

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $7.65, but opened at $7.94. ASP Isotopes shares last traded at $7.53, with a volume of 1,082,124 shares traded.

Analysts Set New Price Targets

A number of equities analysts have recently commented on ASPI shares. Canaccord Genuity Group started coverage on ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective for the company. HC Wainwright lowered their price target on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th.

ASP Isotopes Price Performance

The stock has a fifty day moving average of $5.12 and a 200-day moving average of $3.90. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $358.38 million, a price-to-earnings ratio of -8.23 and a beta of 3.88.

Institutional Investors Weigh In On ASP Isotopes

Large investors have recently modified their holdings of the company. Fielder Capital Group LLC acquired a new stake in shares of ASP Isotopes in the second quarter valued at approximately $55,000. The Manufacturers Life Insurance Company acquired a new stake in shares of ASP Isotopes in the third quarter valued at approximately $52,000. KKM Financial LLC boosted its holdings in shares of ASP Isotopes by 66.2% in the third quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after acquiring an additional 9,000 shares during the period. Sanctuary Advisors LLC acquired a new stake in shares of ASP Isotopes in the third quarter valued at approximately $66,000. Finally, MetLife Investment Management LLC acquired a new stake in shares of ASP Isotopes in the third quarter valued at approximately $88,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.